Tech Company Financing Transactions

TRACON Pharmaceuticals Funding Round

On 4/1/2011, TRACON Pharmaceuticals raised $14 million in financing from Nextech Invest, Rally Ventures and Arcus Ventures.

Transaction Overview

Announced On
4/1/2011
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Investors

Nextech Invest (Lead Investor) (Myoung-Ok Kwon)

Rally Ventures (Lead Investor) (Kenji Harada)

Arcus Ventures

Brookline Venture Partners

Proceeds Purpose
Proceeds from the financing will advance the development of the antibody TRC105, an inhibitor of angiogenesis that is being developed in multiple Phase 1b and Phase 2 indications, that are supported by the National Cancer Institute, including ongoing trials in prostate, bladder and liver cancer.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4350 La Jolla Village Dr. 800
San Diego, CA 92122
USA
Email Address
Overview
TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is a biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis.
Profile
TRACON Pharmaceuticals LinkedIn Company Profile
Social Media
TRACON Pharmaceuticals Company Twitter Account
Company News
TRACON Pharmaceuticals News
Facebook
TRACON Pharmaceuticals on Facebook
YouTube
TRACON Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Charles Theuer
  Charles Theuer LinkedIn Profile  Charles Theuer Twitter Account  Charles Theuer News  Charles Theuer on Facebook
Vice President
Jennifer Ellis
  Jennifer Ellis LinkedIn Profile  Jennifer Ellis Twitter Account  Jennifer Ellis News  Jennifer Ellis on Facebook
VP - Operations
Bonne Adams
  Bonne Adams LinkedIn Profile  Bonne Adams Twitter Account  Bonne Adams News  Bonne Adams on Facebook
VP - Product Management
Sharon Real
  Sharon Real LinkedIn Profile  Sharon Real Twitter Account  Sharon Real News  Sharon Real on Facebook
VP - Regulatory Affairs
Suzy Benedict
  Suzy Benedict LinkedIn Profile  Suzy Benedict Twitter Account  Suzy Benedict News  Suzy Benedict on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/1/2011: OfficeDrop venture capital transaction
Next: 4/1/2011: Forerun venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary